Novel glycosaminoglycan precursors as anti-amyloid agents part II

被引:0
作者
Robert Kisilevsky
Walter A. Szarek
机构
[1] Queen’s University,Department of Pathology
[2] Queen’s University,Department of Chemistry
[3] Kingston General Hospital,The Syl and Molly Apps Research Center
来源
Journal of Molecular Neuroscience | 2002年 / 19卷
关键词
Glycosaminoglycan; heparan sulfate; glucosamine analogues; AA amyloidogenesis;
D O I
暂无
中图分类号
学科分类号
摘要
In vivo amyloids consist of two classes of constituents. The first is the disease defining protein, e.g., Aβ in Alzheimer’s disease. The second is a set of common structural components that usually are the building blocks of basement membrane (BM), a tissue structure that serves as a scaffold onto which cells normally adhere. In vitro binding interactions between one of these BM components and amyloidogenic proteins rapidly change the conformation of the amyloidogenic protein into amyloid fibrils. The offending BM component is a heparan sulfate (HS) proteoglycan (HSPG), part of which is protein and the remainder a specific linear polysaccharide, which is the portion responsible for binding, and imparting the typical amyloid structure, to the amyloid precursor protein/peptide. Our past work has demonstrated that agents that inhibit the binding between HS and the amyloid precursor are effective anti-amyloid compounds both in vitro and in vivo. The present work is concerned with the design and synthesis of modified sugar precursors of HS, which, when incorporated into the polysaccharide, will alter its structure so that it loses its amyloid precursor protein/peptide-binding and fibril-inducing properties.
引用
收藏
页码:45 / 50
页数:5
相关论文
共 63 条
[1]  
Ancsin J. B.(1999)The heparin/heparan sulfate-binding site on apo-serum amyloid A: implications for the therapeutic intervention of amyloidosis J. Biol. Chem. 274 7172-7181
[2]  
Kisilevsky R.(2000)Synthesis of 4-deoxy analogues of 2-acetamido2-deoxy-D-glucose and 2-acetamido-2-deoxy-D-xylose and their effects on glycoconjugate biosynthesis Carbohydr. Res. 325 30-45
[3]  
Berkin A.(2000)Synthesis of 4-deoxy-4-fluoro analogues of 2-acetamido-2-deoxy-D-glucose and 2-acetamido-2-deoxy-D-galactose and their effects on cellular glycosaminoglycan biosynthesis Carbohydr. Res. 326 250-263
[4]  
Szarek M. A.(1998)Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan’s enhancement of islet amyloid polypeptide (amylin) fibril formation Diabetes 47 612-620
[5]  
Plenkiewicz J.(1997)Aβ amyloidogenesis: unique or variation on a systemic theme? Crit. Rev. Biochem. Mol. Biol. 32 361-404
[6]  
Szarek W. A.(1995)Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer’s disease Nature Med. 1 143-148
[7]  
Kisilevsky R.(1995)Structure of heparan sulphate from human brain, with special regard to Alzheimer’s disease Biochem. J. 306 177-184
[8]  
Berkin A.(1996)Selective loss of cerebral keratan sulfate in Alzheimer’s disease J. Biol. Chem. 271 16991-16994
[9]  
Szarek W. A.(1997)Amyloid-specific heparan sulfate from human liver and spleen J. Biol. Chem. 272 26091-26094
[10]  
Kisilevsky R.(1999)Common binding sites for β-amyloid fibrils and fibroblast growth factor-2 in heparan sulfate from human cerebral cortex J. Biol. Chem. 274 30631-30635